79 related articles for article (PubMed ID: 20154487)
1. [Evaluation of pain reduction upon injecting goserelin acetate using an ice pack].
Ikeda K; Ogawa Y; Nagahara H; Xiang Z; Sakurai K; Fukuoka T; Tokunaga S; Nishiguchi Y
Gan To Kagaku Ryoho; 2010 Feb; 37(2):291-3. PubMed ID: 20154487
[TBL] [Abstract][Full Text] [Related]
2. [Ice application for reducing pain associated with goserelin acetate injection].
Ishii K; Nagata C; Koshizaki E; Nishiuchi S
Gan To Kagaku Ryoho; 2013 Oct; 40(10):1361-3. PubMed ID: 24105059
[TBL] [Abstract][Full Text] [Related]
3. [Effect of local cooling at injection site of goserelin acetate for pain relief].
Nukui A; Morita T
Gan To Kagaku Ryoho; 2011 Jun; 38(6):967-72. PubMed ID: 21677488
[TBL] [Abstract][Full Text] [Related]
4. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
5. Does needle size matter? Patient experience of luteinising hormone-releasing hormone analogue injection.
Montgomery BS; Borwell JP; Higgins DM
Prostate Cancer Prostatic Dis; 2005; 8(1):66-8. PubMed ID: 15700050
[TBL] [Abstract][Full Text] [Related]
6. Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group.
de Haes H; Olschewski M; Kaufmann M; Schumacher M; Jonat W; Sauerbrei W;
J Clin Oncol; 2003 Dec; 21(24):4510-6. PubMed ID: 14610048
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of skin icing for reducing pain associated with luteinizing hormone-releasing hormone agonist injection].
Nomura T; Tsunoda K; Ohta S; Doi K; Miyoshi K; Hasegawa Y; Mizutani M
Gan To Kagaku Ryoho; 2014 Feb; 41(2):221-4. PubMed ID: 24743201
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant chemotherapy of premenopausal breast cancer with LH-RH analogue for ovarian protection--a case report].
Asaga S; Ando J; Arai T; Fujii H
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1069-72. PubMed ID: 16044976
[TBL] [Abstract][Full Text] [Related]
9. Goserelin (Zoladex)--its role in early breast cancer in pre- and perimenopausal women.
Jonat W
Br J Cancer; 2001 Nov; 85 Suppl 2(Suppl 2):1-5. PubMed ID: 11900209
[TBL] [Abstract][Full Text] [Related]
10. [A case of premenopausal metastatic breast cancer treated with goserelin plus aromatase inhibitor as second-line endocrine therapy].
Baba S; Oji Y; Teramoto M; Kawabata K; Saito A
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1905-6. PubMed ID: 19920398
[TBL] [Abstract][Full Text] [Related]
11. Goserelin followed by assisted reproduction: results in infertile women with endometriosis.
Ruiz-Velasco V; Allende S
Int J Fertil Womens Med; 1998; 43(1):18-23. PubMed ID: 9532465
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.
Sverrisdóttir A; Fornander T; Jacobsson H; von Schoultz E; Rutqvist LE
J Clin Oncol; 2004 Sep; 22(18):3694-9. PubMed ID: 15365065
[TBL] [Abstract][Full Text] [Related]
13. Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).
Davidson NE; O'Neill AM; Vukov AM; Osborne CK; Martino S; White DR; Abeloff MD
J Clin Oncol; 2005 Sep; 23(25):5973-82. PubMed ID: 16087950
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of LH-RH agonist for bone metastases of breast cancer--report of a case].
Kudoh S; Kawamura H; Suzuki Y; Matsuzaki M; Nishina M; Tsukamoto M
Gan To Kagaku Ryoho; 1996 May; 23(6):787-90. PubMed ID: 8645031
[TBL] [Abstract][Full Text] [Related]
15. Use of goserelin in the treatment of breast cancer.
Rody A; Loibl S; von Minckwitz G; Kaufmann M
Expert Rev Anticancer Ther; 2005 Aug; 5(4):591-604. PubMed ID: 16111461
[TBL] [Abstract][Full Text] [Related]
16. Same gain, less pain: potential patient preferences for adjuvant treatment in premenopausal women with early breast cancer.
Fallowfield L; McGurk R; Dixon M
Eur J Cancer; 2004 Nov; 40(16):2403-10. PubMed ID: 15519512
[TBL] [Abstract][Full Text] [Related]
17. [A new LH-RH agonist for treatment of prostate cancer, 3-month controlled-release formulation of goserelin acetate (Zoladex LA 10.8 mg depot)--outline of pre-clinical and clinical studies].
Tsukagoshi S
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1675-87. PubMed ID: 12355959
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
Bernhard J; Zahrieh D; Castiglione-Gertsch M; Hürny C; Gelber RD; Forbes JF; Murray E; Collins J; Aebi S; Thürlimann B; Price KN; Goldhirsch A; Coates AS;
J Clin Oncol; 2007 Jan; 25(3):263-70. PubMed ID: 17159194
[TBL] [Abstract][Full Text] [Related]
19. CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93).
von Minckwitz G; Graf E; Geberth M; Eiermann W; Jonat W; Conrad B; Brunnert K; Gerber B; Vescia S; Wollert J; Kaufmann M
Eur J Cancer; 2006 Aug; 42(12):1780-8. PubMed ID: 16765589
[TBL] [Abstract][Full Text] [Related]
20. Randomised crossover trial to assess the tolerability of LHRH analogue administration.
Williams G; Lindsay S; Bowsher WG
Prostate Cancer Prostatic Dis; 2003; 6(2):187-9. PubMed ID: 12806381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]